4.7 Article

Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis

Joost Smolders et al.

ACTA NEUROLOGICA SCANDINAVICA (2020)

Review Immunology

Natural killer cells in multiple sclerosis: A review

Max Mimpen et al.

IMMUNOLOGY LETTERS (2020)

Review Clinical Neurology

Neurofilaments: neurobiological foundations for biomarker applications

Arie R. Gafson et al.

BRAIN (2020)

Article Medicine, Research & Experimental

Daclizumab Therapy for Multiple Sclerosis

Bibiana Bielekova

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)

Article Multidisciplinary Sciences

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

Nikolas A. Patsopoulos et al.

SCIENCE (2019)

Review Clinical Neurology

Multiple sclerosis - a review

R. Dobson et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Review Immunology

Reassessing B cell contributions in multiple sclerosis

Rui Li et al.

NATURE IMMUNOLOGY (2018)

Review Immunology

Involvement of CD8+ T Cells in Multiple Sclerosis

Marion Salou et al.

FRONTIERS IN IMMUNOLOGY (2015)

Article Multidisciplinary Sciences

Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells

Felix J. Hartmann et al.

NATURE COMMUNICATIONS (2014)

Article Biochemical Research Methods

Intracellular IL-10 detection in T cells by flowcytometry: The use of protein transport inhibitors revisited

Anne-Hilde Muris et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2012)

Review Clinical Neurology

MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials

Frederik Barkhof et al.

NATURE REVIEWS NEUROLOGY (2012)

Article Clinical Neurology

Intrathecal effects of daclizumab treatment of multiple sclerosis

B. Bielekova et al.

NEUROLOGY (2011)

Article Clinical Neurology

Higher 25-hydroxyvitamin D Is Associated with Lower Relapse Risk in Multiple Sclerosis

Steve Simpson et al.

ANNALS OF NEUROLOGY (2010)

Article Multidisciplinary Sciences

Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab′)2

Jianmei W. Leavenworth et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Clinical Neurology

T-Helper 17 Cells Expand in Multiple Sclerosis and Are Inhibited by Interferon-β

Luca Durelli et al.

ANNALS OF NEUROLOGY (2009)

Article Biochemistry & Molecular Biology

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

Hania Kebir et al.

NATURE MEDICINE (2007)

Review Medicine, Research & Experimental

APC-derived cytokines and T cell polarization in autoimmune inflammation

Ilona Gutcher et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Multidisciplinary Sciences

Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis

B Bielekova et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)